ProPhase Labs
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $3,146 | $2,474 | $3,634 | $3,499 |
Gross Profit | -165 | -476 | -433 | -3,056 |
EBITDA | -5,431 | -6,068 | -6,520 | -9,233 |
EBIT | -7,937 | -7,797 | -8,316 | -11,171 |
Net Income | -6,587 | -6,153 | -6,265 | -8,751 |
Net Change In Cash | 3,146 | 2,474 | 3,634 | 3,499 |
Free Cash Flow | -4,206 | -4,844 | -6,058 | -1,523 |
Cash | 501 | 1,780 | 1,736 | 2,149 |
Basic Shares | 19,079 | 18,888 | 18,045 | 18,045 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $44,384 | $122,647 | $79,042 | $14,514 |
Gross Profit | 16,239 | 70,654 | 32,814 | 4,606 |
EBITDA | -14,827 | 28,733 | 11,388 | -1,488 |
EBIT | -21,525 | 23,672 | 6,453 | -2,019 |
Net Income | -16,782 | 18,463 | 6,273 | -2,420 |
Net Change In Cash | 44,384 | 122,647 | 79,042 | 14,514 |
Cost of Revenue | 11,566 | |||
Free Cash Flow | -14,503 | 24,632 | -17,850 | -4,281 |
Cash | 1,609 | 9,109 | 8,408 | 6,816 |
Basic Shares | 17,207 | 18,651 | 18,393 | 11,595 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.35 |
2024-06-30 | -$0.33 |
2024-03-31 | -$0.07 |
2023-12-31 | -$0.51 |
